Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - OPERATING INCOME
Operating Income OCX - OncoCyte Corporation
-25.1 M
LAST VALUE
26.83%
2 YEAR CAGR
-10.58%
5 YEAR CAGR
-21.81%
10 YEAR CAGR